FPI 2107
Alternative Names: [111In]-FPI-2107; FPI-2107Latest Information Update: 10 Jun 2024
At a glance
- Originator Fusion Pharmaceuticals
- Class Antineoplastics; Diagnostic agents; Radioisotopes; Radiopharmaceuticals
- Mechanism of Action Diagnostic imaging enhancers; Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Cancer